Halozyme Therapeutics Inc. (HALO) News Nov 20, 2014, 5:14

New Post Public Reply Private Reply Replies (0) Message Board

Nov 20, 2014 at 8:38 PM

Halozyme Therapeutics Inc. (HALO) News Nov 20, 2014, 5:14 p.m.
MarketWatch News on HALO
Fossil Group swings higher on earnings beat, license renewal 6:30 a.m. Nov. 12, 2014 - Wallace Witkowski
Amazon gains on June event; PVH sinks on results 2:36 p.m. June 5, 2014 - Sue Chang
Stock futures rise after ECB moves, claims report 8:00 a.m. June 5, 2014 - Barbara Kollmeyer
ECB, jobs report could finally ignite the stock-market powder keg 7:46 a.m. June 5, 2014 - Shawn Langlois
PVH falls, Halozyme, Five Below, gain after hours 3:51 p.m. June 4, 2014 - Myra P. Saefong
Rackspace shares surge after hours on earnings 5:10 p.m. May 12, 2014 - Wallace Witkowski
Halozyme temporarily halts dosing in cancer study 8:27 a.m. April 4, 2014 - MarketWatch.com
A Morgan Stanley buy, Alcoa's report and the streaker opens up 7:18 a.m. Oct. 8, 2013 - Shawn Langlois
Halozyme shares jump on Roche $10 million milestone payment 11:40 a.m. Sept. 27, 2013 - Russ Britt
Isis, Novartis, Halozyme all rise on positive product news 10:48 a.m. Sept. 3, 2013 - Russ Britt
European regulators smile on small biotech Halozyme, and shares soar 5:22 p.m. June 28, 2013 - Russ Britt
Little-noticed firm makes a splash with pancreatic cancer treatment 1:25 p.m. May 16, 2013 - Russ Britt
6 gut checks before the stock market's opening bell 5:49 a.m. March 25, 2013 - Shawn Langlois
Synageva director bought shares for trust 1:41 p.m. Jan. 17, 2013 - Insider Monkey
Friday’s biggest gaining and declining stocks 3:51 p.m. Dec. 21, 2012 - Matt Andrejczak
ViroPharma gets okay to test reformulated Cinryze 12:09 p.m. Sept. 21, 2012 - MarketWatch.com
Halozyme soars 27% on Cinryze drug update 10:51 a.m. Sept. 21, 2012 - Val Brickates Kennedy
FDA lifts temporary hold on ViroPharma treatment 7:30 a.m. Sept. 21, 2012 - MarketWatch.com
Halozyme rebounds 12% in midday trading 10:21 a.m. Aug. 3, 2012 - Val Brickates Kennedy

Other News on HALO
Biggest Movers in Healthcare Stocks Now – CLDX ALGN WST PDCO 12:45 p.m. Nov. 12, 2014 - InvestorPlace.com
Halozyme Therapeutics (HALO) Stock Is Slipping Today on Weak Third Quarter Earnings 11:42 a.m. Nov. 11, 2014 - TheStreet.com
Halozyme Therapeutics' (HALO) CEO Helen Torley on Q3 2014 Results - Earnings Call Transcript 9:33 p.m. Nov. 10, 2014 - Seeking Alpha
10-Q: HALOZYME THERAPEUTICS INC 4:50 p.m. Nov. 10, 2014 - Edgar Online - (EDG = 10Q, 10K)
Halozyme Therapeutics Plummets On Q3 Losses 4:19 p.m. Nov. 10, 2014 - benzinga.com
NewLink Genetics Corporation (NLNK) in Focus: Stock Soars 15.4% - Tale of the Tape 9:18 a.m. Oct. 23, 2014 - Zacks.com
Vertex Pharmaceuticals' Kalydeco Wins FDA Panel Backing - Analyst Blog 5:54 p.m. Oct. 22, 2014 - Zacks.com
Biogen's Q3 Earnings Top Estimates, View Raised Again - Analyst Blog 1:10 p.m. Oct. 22, 2014 - Zacks.com
Actelion Misses Q3 Earnings Expectation, Ups 2014 Guidance - Analyst Blog 11:40 a.m. Oct. 22, 2014 - Zacks.com
Orexigen (OREX) Shows Strength: Stock Gains 11.1% - Tale of the Tape 9:25 a.m. Oct. 22, 2014 - Zacks.com
Illumina (ILMN) Looks Strong: Stock Gains 9.2% - Tale of the Tape 8:44 a.m. Oct. 22, 2014 - Zacks.com
NewLink-Roche Ink Deal for Oncology Candidate Development - Analyst Blog 6:05 p.m. Oct. 21, 2014 - Zacks.com
Illumina (ILMN) Tops Q3 Earnings, Revenues; Ups Guidance - Analyst Blog 9:40 a.m. Oct. 21, 2014 - Zacks.com
Vital Therapies (VTL) in Focus: Stock Adds 7.9% in Session - Tale of the Tape 9:39 a.m. Oct. 21, 2014 - Zacks.com
NewLink Genetics Corp. (NLNK) Jumps: Stock Rises 7.1% - Tale of the Tape 8:51 a.m. Oct. 21, 2014 - Zacks.com
Amicus Reports Additional Positive Data on Fabry Therapy - Analyst Blog 6:35 p.m. Oct. 20, 2014 - Zacks.com
Regeneron Pharmaceuticals (REGN) Jumps: Stock Up 8.5% - Tale of the Tape 9:39 a.m. Oct. 20, 2014 - Zacks.com
Emergent BioSolutions (EBS) Jumps: Stock Moves Up 5.8% - Tale of the Tape 8:51 a.m. Oct. 20, 2014 - Zacks.com
Ultragenyx Reports Data from Sialic Acid Deficiency Study - Analyst Blog 5:00 p.m. Oct. 17, 2014 - Zacks.com
Novavax (NVAX) Moves Up: Stock Adds 10.1% in Session - Tale of the Tape 9:39 a.m. Oct. 17, 2014 - Zacks.com

Press Releases on HALO
Halozyme Reports Third Quarter 2014 Financial Results 4:05 p.m. Nov. 10, 2014 - PR Newswire - PRF
Halozyme Therapeutics To Present At The Credit Suisse Healthcare Conference 4:15 p.m. Nov. 5, 2014 - PR Newswire - PRF
Halozyme to Host Third Quarter 2014 Financial Results Conference Call 4:15 p.m. Nov. 3, 2014 - PR Newswire - PRF
Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 7:40 a.m. Oct. 31, 2014 - PR Newswire - PRF
Baxter Launches HYQVIA in the United States for Adult Patients with Primary Immunodeficiency 8:02 a.m. Oct. 20, 2014 - BusinessWire - BZX
Halozyme Receives FDA Approval For Additional Manufacturing Facilities For Hylenex® Recombinant 7:30 a.m. Oct. 20, 2014 - PR Newswire - PRF
Halozyme Announces Podium Presentation On PEGPH20 At The New York Academy Of Sciences 8:00 a.m. Oct. 9, 2014 - PR Newswire - PRF
Halozyme Announces Issuance Of U.S. Patent For Companion Diagnostic For PEGPH20 7:30 a.m. Oct. 7, 2014 - PR Newswire - PRF
Halozyme Receives Orphan Drug Designation For PEGylated Recombinant Human Hyaluronidase PH20 For Pancreatic Cancer 6:45 a.m. Oct. 3, 2014 - PR Newswire - PRF
SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 8:00 a.m. Sept. 18, 2014 - PR Newswire - PRF
Biotech Stocks in Motion - XOMA, Nanosphere, Isis Pharma, Halozyme Therapeutics, and Synta Pharma 7:45 a.m. Sept. 17, 2014 - PR Newswire - PRF
FDA Approves Baxter’s HYQVIA for Treatment of Adults with Primary Immunodeficiency 6:02 p.m. Sept. 12, 2014 - BusinessWire - BZX
Halozyme's PEGPH20 Program In Metastatic Pancreatic Cancer Receives Fast Track Designation 7:30 a.m. Sept. 3, 2014 - PR Newswire - PRF
Expert Briefing on Biotech Stocks -- Nanosphere, Vanda Pharma, Synta Pharma, Halozyme Therapeutics, and Isis Pharma 8:30 a.m. Aug. 14, 2014 - PR Newswire - PRF
Halozyme to Host second Quarter 2014 Financial Results Conference Call 3:30 p.m. Aug. 4, 2014 - PR Newswire - PRF
FDA Advisory Committee Panel Provides Favorable Recommendation on Baxter’s HyQvia for Primary Immunodeficiency 12:55 p.m. July 31, 2014 - BusinessWire - BZX
Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer 8:00 a.m. July 22, 2014 - PR Newswire - PRF
Pre-market Equity Watch on Biotech Industry -- Research on Halozyme Therapeutics, XOMA, Amicus Therapeutics, and Arena Pharma 6:20 a.m. July 10, 2014 - PR Newswire - PRF
New Drug Applications, Agreements, Launches, and Appointments - Analyst Notes on Curis, Enzo Biochem, AGTC, Halozyme and Magellan Health 5:20 a.m. July 2, 2014 - PR Newswire - PRF
Roche's Commercial Launch Of MabThera SC Triggers Milestone Payment To Halozyme 7:00 a.m. June 25, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Global Movement Urges Dr. Hak Ja Han's Release

Under the shadows of Manhattan's skyline, something more than a regular service took shape. The New Yorker Hotel hosted an impassioned gathering of the Family Federation for World Peace and Unification. These folks weren't just saying their prayers; they were making a call—loud and resonant—for the release of Dr. Hak Ja Han. The Power of Collective Voices Gathering in...

Baidu's Stock Connect Inclusion: What It Means for Investors

An Intriguing Move For Baidu's Class A Shares Well, here we go again, folks. Another move on the chessboard for Baidu. They've just walked their Class A ordinary shares onto the Shenzhen-Hong Kong and Shanghai-Hong Kong Stock Connects. As of today, September 7, 2026, mainland investors can now get their mitts on these shares more easily. It might not be a...

WEPSEA 2026 Propels Southeast Asia's Packaging Leap

Revolution in Packaging: Southeast Asia Steps Up Get ready for a wake-up call in the world of packaging, folks; the Southeast Asian market is taking a sharp turn toward sustainability and technological advancement, as highlighted by WEPSEA 2026's recent wrap-up in Shanghai. Far from a mere exhibition, this gathering served as the crucible for change, where old-school...

Bad Bunny Super Bowl Halftime Show Sweeps 7 Emmy Wins

An Unprecedented Performance: A Halftime Show for the Ages Hold onto your hats, folks—Bad Bunny and his Super Bowl LX Halftime Show have taken home a jaw-dropping seven Emmys at the 78th Emmy Awards. This is uncharted territory for any Super Bowl Halftime Show. Never before has a halftime spectacle swept the Emmys like this. We’re talking about categories such as...

Mermaid Folklore Meets Revolution in New Short Film

A Sea Haunting Like No Other Ever feel like history's forgotten tales deserve a fresh spin? Well, this one's shaking it up! Hoyt Dwyer, an Atlanta filmmaker, flips the script on a lesser-known bit from the American Revolution. Yeah, we're talking about Hessian soldiers and sirens here. Just hang on to your hats because this ain't your typical historical retelling. A...

MERACH Unveils W60 Plus: A Game Changer for Home Fitness

MERACH's Ambitious Leap into European Markets Walking is one of life's simple pleasures, but it's not always convenient in our work-from-home driven world. That's where MERACH's UltraWalk W60 Plus comes in, dropping anchor in Europe like a brand new ship with all the bells and whistles. What makes this walking pad different, you ask? It's designed to become a natural...

Hims & Hers Faces Class Action: Investors Beware

Allegations and Legal Pressure There's trouble brewing in the land of health and wellness apps, with Hims & Hers Health, Inc. (NYSE:HIMS) taking center stage. Slap on your glasses, folks, because this one's a doozy. A class-action lawsuit has exploded against the company and some of its officers—allegations flying as they focus on serious accusations of misleading...

Media Forum Spotlights Asia-Pacific Cooperation

The Opening Scene: A Gathering with Purpose Well, here we go, diving right into the latest shindig in Shenzhen at the Asia-Pacific Media Forum. Held in China's Guangdong province, they've rounded up over 400 reps from every corner of the globe, all chewing over one key theme: "Building a Path to Shared Prosperity for the Asia-Pacific Community." You could say it's a step...

Softcare Facilitates Standards Delegation Visit to Senegal

Ever seen a whole nation's hygiene industry getting a deep dive from not just one, but three major standards bodies? That's what just went down in Senegal. Softcare opened its doors wide to folks from the Senegalese Association for Standardization (ASN), the International Organization for Standardization (ISO), and the Swedish Institute for Standards (SIS). This was no...

DUVA ONE Sleep Earbuds: Real-Time Innovation Debuts

While You Dream, DUVA ONE Works Here's the scoop: DUVA just took sleep tech to another level with their DUVA ONE earbuds launched at Berlin's IFA 2026. These aren't just any earbuds; they're engineered to actually do something while you're sleeping. DUVA ONE senses what’s happening during your snooze session and adjusts right on the fly. The Night Patrol: In-Ear and...